PROUD Study: A Prospective Study on the Usage Patterns of Doripenem in the Asia Pacific Region
A Prospective Study on the Usage Patterns of Doripenem in the Asia Pacific Region
Sponsor: Janssen Research & Development, LLC
Listed as NCT00986102, this PHASE4 trial focuses on Pneumonia and Pneumonia, Ventilator-Associated and remains completed. Sponsored by Janssen Research & Development, LLC, it has been updated 7 times since 2009, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.
Status Flow
Change History
7 versions recorded-
Sep 2025 — Present [monthly]
Completed PHASE4
-
Dec 2024 — Sep 2025 [monthly]
Completed PHASE4
-
Sep 2024 — Dec 2024 [monthly]
Completed PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE4
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE4
▶ Show 2 earlier versions
-
Jun 2018 — Jan 2021 [monthly]
Completed PHASE4
-
Jan 2017 — Jun 2018 [monthly]
Completed PHASE4
First recorded
Jul 2009
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Janssen Research & Development, LLC
- Johnson & Johnson (Hong Kong) Ltd.
For direct contact, visit the study record on ClinicalTrials.gov .